Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 206
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01688193 | Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male | ||
| NCT01724814 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A | ||
| NCT04946903 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008 | ||
| NCT07219589 | A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants | ||
| NCT06174779 | A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus | ||
| NCT03684642 | Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin | ||
| NCT01894399 | Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects | ||
| NCT04080726 | Efficacy and Safety of HIP1601 Capsule | ||
| NCT05462535 | An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet | ||
| NCT03212625 | The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction | ||
| NCT04325620 | Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease | ||
| NCT01573663 | A Drug-Drug Interaction Study of Ambroxol and Levodropropizine | ||
| NCT04775706 | Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects | ||
| NCT01447797 | A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin | ||
| NCT05723549 | A Study to Evaluate the PK, Safety and Tolerability of HCP1803. | ||
| NCT01491503 | A Drug Interaction Study of Montelukast and Levocetirizine | ||
| NCT06357910 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions | ||
| NCT04084184 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects | ||
| NCT01929512 | Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg | ||
| NCT00954304 | Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet | ||
| NCT02205606 | Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia | ||
| NCT03496298 | Effect of Efpeglenatide on Cardiovascular Outcomes | ||
| NCT03330314 | Molar Potency Study of HM12460A in Healthy Subjects | ||
| NCT03713684 | Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s) | ||
| NCT04967014 | Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers | ||
| NCT02712411 | Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers | ||
| NCT06234397 | Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors | ||
| NCT04764201 | The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers | ||
| NCT01013064 | A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects | ||
| NCT07359105 | Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study) | ||
| NCT03228277 | Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA | ||
| NCT03426722 | L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors | ||
| NCT01093729 | A Study of HM11260C in Healthy Male Subject | ||
| NCT01588145 | Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients | ||
| NCT04322266 | A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects. | ||
| NCT04252872 | Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male Volunteers | ||
| NCT05422677 | An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia | ||
| NCT02899455 | Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia | ||
| NCT01491217 | A Study of Oraxol® in Gastric Cancer Patients | ||
| NCT03089112 | Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501 | ||
| NCT04032782 | A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects | ||
| NCT02390882 | A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH | ||
| NCT02941796 | Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers | ||
| NCT04510415 | Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI | ||
| NCT06438172 | A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension | ||
| NCT02523547 | Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude | ||
| NCT01452451 | Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus | ||
| NCT04081857 | A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects | ||
| NCT05191563 | A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects. | ||
| NCT04081844 | A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects. |
